Chemomab Therapeutics Ltd - ADR

NASDAQ:CMMB   3:59:52 PM EDT
7.91
+0.48 (+6.46%)
Earnings Announcements

Chemomab Therapeutics Announces Third Quarter 2021 Financial Results

Published: 11/12/2021 12:41 GMT
Chemomab Therapeutics Ltd - ADR (CMMB) - Chemomab Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update.
Q3 Loss per Share $0.01.
Existing Cash Position is Expected to Fund Company's Current Operating Plan Until Mid-2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.02

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.02

More details on our Analysts Page.